Skip to main content

Lumos Pharma, Inc.

LUMODelisted Dec 12, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001126234

Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Lumos Pharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

LUMO is no longer listed, so this page shows Q3 2024. 13F filings for later quarters list far fewer holders.

Institutional holders
29
−6 vs. Q2 2024
Shares held
2.09M
+51.3K (+2.5%) vs. Q2 2024
Total value
$8.08M
+$3.36M (+71.0%) vs. Q2 2024
New holders
3
2 more added
Sold out
9
11 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LUMO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 29 institutions
Q1 2021: 41 institutionsQ2 2021: 40 institutionsQ3 2021: 37 institutionsQ4 2021: 38 institutionsQ1 2022: 36 institutionsQ2 2022: 36 institutionsQ3 2022: 35 institutionsQ4 2022: 38 institutionsQ1 2023: 37 institutionsQ2 2023: 35 institutionsQ3 2023: 34 institutionsQ4 2023: 37 institutionsQ1 2024: 36 institutionsQ2 2024: 36 institutionsQ3 2024: 29 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $8.08M
Q1 2021: $38.8MQ2 2021: $32.1MQ3 2021: $27.3MQ4 2021: $18.7MQ1 2022: $23.3MQ2 2022: $18.7MQ3 2022: $23.0MQ4 2022: $8.51MQ1 2023: $7.40MQ2 2023: $7.90MQ3 2023: $8.05MQ4 2023: $7.52MQ1 2024: $6.14MQ2 2024: $4.82MQ3 2024: $8.08MQ4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding LUMO and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 202429$8.08M
Q2 202436$4.82M
Q1 202436$6.14M
Q4 202337$7.52M
Q3 202334$8.05M
Q2 202335$7.90M
Q1 202337$7.40M
Q4 202238$8.51M
Q3 202235$23.0M
Q2 202236$18.7M
Q1 202236$23.3M
Q4 202138$18.7M
Q3 202137$27.3M
Q2 202140$32.1M
Q1 202141$38.8M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Lumos Pharma, Inc.; share changes are against Q2 2024.

Institutions holding LUMO in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Private Advisor Group, LLC744,513$2.88M0.02%+714,500+2,380.6%Added
Goldman Sachs Group Inc362,198$1.40M0.00%−44,413−10.9%Reduced
Vanguard Group Inc244,082$944.6K0.00%00.0%Unchanged
Renaissance Technologies LLC213,814$827.5K0.00%−2,000−0.9%Reduced
Jefferies Financial Group Inc.120,651$466.9K0.01%00.0%Unchanged
Greenwich Wealth Management LLC76,341$295.0K0.02%00.0%Unchanged
Wells Fargo & Company64,981$251.5K0.00%−350,000−84.3%Reduced
Geode Capital Management, LLC55,148$213.5K0.00%+4,421+8.7%Added
BlackRock, Inc.39,825$154.1K0.00%+39,825New
Lion Point Capital, LP39,589$153.2K0.61%−51,205−56.4%Reduced
Dimensional Fund Advisors LP25,278$97.8K0.00%−4,309−14.6%Reduced
Bridgeway Capital Management, LLC19,643$76.0K0.00%−8,000−28.9%Reduced
Bank of New York Mellon Corp11,858$45.9K0.00%00.0%Unchanged
Wealth Advisors of Iowa, LLC11,699$45.3K0.02%00.0%Unchanged
State Street Corp11,237$43.5K0.00%00.0%Unchanged
Two Sigma Investments, LP11,130$43.1K0.00%−7,815−41.3%Reduced
Key Financial Inc10,927$42.3K0.01%00.0%Unchanged
ADAR1 Capital Management, LLC10,000$38.7K0.01%+10,000New
UBS Group AG6,557$25.4K0.00%+6,557New
Paladin Advisory Group, LLC4,387$17.0K0.01%00.0%Unchanged
Bank of America Corp1,800$6.97K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,225$4.74K0.00%−2,357−65.8%Reduced
West Financial Advisors, LLC784$3.04K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.290$1.12K0.00%−20−6.5%Reduced
Morgan Stanley166$6420.00%−111−40.1%Reduced
JPMorgan Chase & Co13$500.00%00.0%Unchanged
Live Oak Investment Partners–$430.00%––
Jones Financial Companies LLLP4$160.00%00.0%Unchanged
Royal Bank of Canada50$00.00%−28−35.9%Reduced
Acuitas Investments, LLC0$00.00%−141,435−100.0%Sold out
Millennium Management LLC0$00.00%−37,018−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−25,760−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−19,475−100.0%Sold out
Citadel Advisors LLC0$00.00%−18,745−100.0%Sold out
Atria Investments LLC0$00.00%−10,803−100.0%Sold out
Redwood Wealth Management Group, LLC0$00.00%−500−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−38−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−3−100.0%Sold out
BlackRock Inc.––––Not filed